肝细胞癌影像组学研究进展及其在临床的应用
Progress in Imaging Omics Research of Hepatocellular Carcinoma and Its Clinical Application
DOI: 10.12677/ACM.2023.1351135, PDF,   
作者: 夏弘婧*, 鲍海华#, 曹云太, 谭华清：青海大学附属医院影像中心，青海 西宁
关键词: 肝癌；影像组学；临床应用；Liver Cancer； Imaging Omics； Clinical Application
摘要: 肝细胞癌(HCC)是世界上第六大常见癌症，也是癌症相关死亡的第三大原因。虽然目前HCC的诊断方案正在不断完善，但HCC的预后仍不理想。影像组学作为一个新的领域，可从不同类型的图像中提取高通量成像数据，在手术前无创地建立模型并预测临床结果。已发表的关于HCC放射组学分析的研究提供了令人鼓舞的数据，证明了在预测肿瘤生物学、分子谱、治疗后反应和结果方面的潜在效用，所以本文将从影像组学的基本流程入手，结合其在临床不同方面的应用进行综述。
Abstract: Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world and the third leading cause of cancer-related deaths. Although the diagnostic protocol for HCC is currently being continu-ously improved, the prognosis of HCC is still not ideal. Imaging omics, as a new field, can extract high-throughput imaging data from different types of images, non-invasively establish models be-fore surgery, and predict clinical outcomes. The published research on radiomics analysis of HCC provides encouraging data, demonstrating its potential utility in predicting tumor biology, molecu-lar spectra, post treatment reactions, and outcomes. Therefore, this article will start with the basic process of radiomics and review its clinical applications in different aspects.
文章引用：夏弘婧, 鲍海华, 曹云太, 谭华清. 肝细胞癌影像组学研究进展及其在临床的应用[J]. 临床医学进展, 2023, 13(5): 8116-8121. https://doi.org/10.12677/ACM.2023.1351135

参考文献

[1] Villanueva, A. (2019) Hepatocellular Carcinoma. New England Journal of Medicine, 380, 1450-1462. [Google Scholar] [CrossRef] 
[2] Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[3] Kumari, R., Sahu, M.K., Tripathy, A., Uthansingh, K. and Behera, M. Hepatocellular Carcinoma Treatment: Hurdles, Advances and Prospects. Hepatic Oncology, 5, Article No. HEP08.[CrossRef] [PubMed]
[4] 周正平, 纪小龙. 肝细胞癌介入治疗后切除病肝标本4例病理学观察[J]. 临床与实验病理学杂志, 2012, 28(10): 1167-1169. [Google Scholar] [CrossRef] 
[5] Hricak, H. (2011) Oncologic Imaging: A Guiding Hand of Personalized Cancer Care. Radiology, 259, 633-640. [Google Scholar] [CrossRef] [PubMed]
[6] Sharma, B., Martin, A., Stanway, S., Johnston, S.R.D. and Constan-tinidou, A. (2012) Imaging in Oncology—Over a Century of Advances. Nature Reviews Clinical Oncology, 9, 728-737. [Google Scholar] [CrossRef] [PubMed]
[7] 侯震, 李双双, 闫婧, 万遂人. 影像组学在食管癌放疗中的应用研究进展[J]. 中华放射医学与防护杂志, 2018, 38(3): 236-240.
[8] Lambin, P., Rios-Velazquez, E., Leijenaar, R., et al. (2012) Radiomics: Extracting More Information from Medical Images Using Advanced Feature Analysis. Europe-an Journal of Cancer, 48, 441-446. [Google Scholar] [CrossRef] [PubMed]
[9] 刘同刚. MiR-709下调GPC5表达促进肝癌细胞增殖、侵袭和转移的机制研究[D]: [博士学位论文]. 天津: 天津医科大学, 2017.
[10] 金玉梅, 王叶武, 张军, 程彦达, 冯敏, 宋彬. 影像组学在混合型肝癌与肝内胆管细胞癌鉴别诊断中的价值[J]. 中国CT和MRI杂志, 2021, 19(11): 118-122+126.
[11] Liu, X., Khalvati, F., Namdar, K., et al. (2021) Can Machine Learning Radiomics Provide Pre-Operative Differentiation of Combined Hepatocellular Cholangiocarcinoma from Hepatocellular Carcinoma and Cholangiocarcinoma to Inform Optimal Treatment Planning? European Radiology, 31, 244-255. [Google Scholar] [CrossRef] [PubMed]
[12] 王慧慧, 赵心明, 郭炜, 邢古生, 杨蕾, 朱正, 梁萌. 增强CT纹理特征在鉴别肝脏局灶性结节性增生与肝细胞肝癌中的应用价值[J]. 癌症进展, 2017, 15(5): 576-579+583.
[13] Liang, W., Shao, J., Liu, W., et al. (2020) Differentiating Hepatic Epithelioid Angiomyolipoma from Hepatocellular Carcinoma and Focal Nodular Hyperplasia via Radiomics Models. Frontiers in Oncology, 10, Article ID: 564307. [Google Scholar] [CrossRef] [PubMed]
[14] Miyata, R., Tanimoto, A., Wakabayashi, G., et al. (2006) Accuracy of Preoperative Prediction of Microinvasion of Portal Vein in Hepatocellular Carcinoma Using Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging and Computed Tomography during Hepatic Angiography. Journal of Gastroenterology, 41, 987-995. [Google Scholar] [CrossRef] [PubMed]
[15] Bakr, S., Echegaray, S., Shah, R., et al. (2017) Noninvasive Ra-diomics Signature Based on Quantitative Analysis of Computed Tomography Images as a Surrogate for Microvascular Invasion in Hepatocellular Carcinoma: A Pilot Study. Journal of Medical Imaging, 4, Article ID: 041303. [Google Scholar] [CrossRef] 
[16] Ma, X., Wei, J., Gu, D., et al. (2019) Preoperative Radiomics Nomogram for Microvascular Invasion Prediction in Hepatocellular Carcinoma Using Contrast-Enhanced CT. European Radiology, 29, 3595-3605. [Google Scholar] [CrossRef] [PubMed]
[17] Yang, L., Gu, D., Wei, J., et al. (2019) A Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma. Liver Cancer, 8, 373-386. [Google Scholar] [CrossRef] [PubMed]
[18] Sasaki, A., Kai, S., Iwashita, Y., et al. (2005) Microsatellite Distribution and Indication for Locoregional Therapy in Small Hepatocellular Carcinoma. Cancer, 103, 299-306. [Google Scholar] [CrossRef] [PubMed]
[19] Ng, I.O.L., Lai, E.C.S., Fan, S.T., Ng, M.M.T. and So, M.K.P. (1995) Prognostic Significance of Pathologic Features of Hepatocellular Carcinoma a Multivariate Analysis of 278 Patients. Cancer, 76, 2443-2448. [Google Scholar] [CrossRef] 
[20] Xu, X., Zhang, H.-L., Liu, Q.-P., et al. (2019) Radiomic Analysis of Contrast-Enhanced CT Predicts Microvascular Invasion and Outcome in Hepatocellular Carcinoma. Journal of Hepatology, 70, 1133-1144. [Google Scholar] [CrossRef] [PubMed]
[21] Okusaka, T., Okada, S., Ueno, H., et al. (2002) Satellite Lesions in Patients with Small Hepatocellular Carcinoma with Reference to Clinicopathologic Features. Cancer, 95, 1931-1937. [Google Scholar] [CrossRef] [PubMed]
[22] 宁培钢, 高飞, 海金金, 武明辉, 陈健, 朱绍成, 王梅云, 史大鹏. 基于增强CT放射组学预测肝细胞肝癌病理分级[J]. 中国医学影像技术, 2020, 36(7): 1051-1056. [Google Scholar] [CrossRef] 
[23] Bruix, J. and Sherman, M. (2005) Management of Hepatocellular Carcinoma. Hepatology, 42, 1208-1236. [Google Scholar] [CrossRef] [PubMed]
[24] Wu, M.H., Tan, H.N., Gao, F., Hai, J.J., et al. (2019) Predicting the Grade of Hepatocellular Carcinoma Based on Non-Contrast-Enhanced MRI Radiomics Signature. European Radiology, 29, 2802-2811. [Google Scholar] [CrossRef] [PubMed]
[25] Filmus, J., Capurro, M. and Rast, J. (2008) Glypicans. Genome Biology, 9, Article No. 224. [Google Scholar] [CrossRef] [PubMed]
[26] Fu, S.-J., Qi, C.-Y., Xiao, W.-K., Li, S.-Q., Peng, B.-G. and Liang, L.-J. (2013) Glypican-3 Is a Potential Prognostic Biomarker for Hepatocellular Carcinoma after Curative Resection. Sur-gery, 154, 536-544. [Google Scholar] [CrossRef] [PubMed]
[27] Yasuda, E., Kumada, T., Toyoda, H., et al. (2010) Evaluation for Clinical Utility of GPC3, Measured by a Commercially Available ELISA Kit with Glypican-3 (GPC3) Antibody, as a Serological and Histological Marker for Hepatocellular Carcinoma. Hepatology Research, 40, 477-485. [Google Scholar] [CrossRef] 
[28] 殷燮灵, 陈钟. 复发性肝癌重复肝切除术与射频消融治疗现状[J]. 南通大学学报(医学版), 2019, 39(2): 104-108. [Google Scholar] [CrossRef] 
[29] 王勇, 任翱, 唐元贵. 脾脏体积对肝癌术后预后的意义[J]. 肝脏, 2018, 23(8): 733-735. [Google Scholar] [CrossRef] 
[30] Chan, A.W.H., Zhong, J., Berhane, S., et al. (2018) Development of Pre and Post-Operative Models to Predict Early Recurrence of Hepatocellular Carcinoma after Surgical Resection. Journal of Hepatology, 69, 1284-1293. [Google Scholar] [CrossRef] [PubMed]
[31] Ji, G.-W., Zhu, F.-P., Xu, Q., et al. (2019) Machine-Learning Analysis of Contrast-Enhanced CT Radiomics Predicts Recurrence of Hepatocellular Carcinoma after Resection: A Mul-ti-Institutional Study. EBioMedicine, 50, 156-165. [Google Scholar] [CrossRef] [PubMed]
[32] Guo, D.H., Gu, D.S., Wang, H.H., et al. (2019) Radiomics Analysis Enables Recurrence Prediction for Hepatocellular Carcinoma after Liver Transplantation. European Journal of Radiology, 117, 33-40. [Google Scholar] [CrossRef] [PubMed]
[33] Zhang, Z., Jiang, H.Y., Chen, J., et al. (2019) Hepatocellular Car-cinoma: Radiomics Nomogram on Gadoxetic Acid-Enhanced MR Imaging for Early Postoperative Recurrence Prediction. Cancer Imaging, 19, Article No. 22. [Google Scholar] [CrossRef] [PubMed]
[34] Yuan, C.W., Wang, Z.C., Gu, D. S., et al. (2019) Prediction Early Recurrence of Hepatocellular Carcinoma Eligible for Curative Ablation Using a Radiomics Nomogram. Cancer Imaging, 19, Article No. 21. [Google Scholar] [CrossRef] [PubMed]
[35] Hamm, C.A., Wang, C.J., Savic, L.J., Ferrante, M., Schobert, I., Schlachter, T., et al. (2019) Deep Learning for Liver Tumor Diagnosis Part I: Development of a Convolutional Neural Network Classifier for Multi-Phasic MRI. European Radiology, 29, 3338-3347. [Google Scholar] [CrossRef] [PubMed]
[36] Shan, Q.-Y., Hu, H.-T., Feng, S.-T., et al. (2019) CT-Based Peritumoral Radiomics Signatures to Predict Early Recurrence in Hepatocellular Carcinoma after Curative Tumor Resec-tion or Ablation. Cancer Imaging, 19, Article No. 11. [Google Scholar] [CrossRef] [PubMed]
[37] 魏炜, 刘振宇, 王硕, 田捷. 影像组学技术研究进展及其在结直肠癌中的临床应用[J]. 中国生物医学工程学报, 2018, 37(5): 513-520.

为你推荐